Evidence map›Paper›PMID 28558200›Full record

ArticleAnalytical chemistry2017

Multiplexed Lipid Bilayers on Silica Microspheres for Analytical Screening Applications.

Nadiezda Fernandez Oropeza, Nesia A Zurek, Mirella Galvan-De La Cruz, Aurora Fabry-Wood, Jennifer M Fetzer, Steven W Graves, Andrew P Shreve

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Fluorescent Lipo-Beads for the Sensitive Detection of Phospholipase AACS biomaterials science & engineering · 2020
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nadiezda Fernandez OropezaCenter for Biomedical Engineering, and ‡Department of Chemical and Biological Engineering, University of New Mexico , Albuquerque, New Mexico 87131, United States.
Nesia A ZurekCenter for Biomedical Engineering, and ‡Department of Chemical and Biological Engineering, University of New Mexico , Albuquerque, New Mexico 87131, United States.
Mirella Galvan-De La CruzCenter for Biomedical Engineering, and ‡Department of Chemical and Biological Engineering, University of New Mexico , Albuquerque, New Mexico 87131, United States.
Aurora Fabry-WoodCenter for Biomedical Engineering, and ‡Department of Chemical and Biological Engineering, University of New Mexico , Albuquerque, New Mexico 87131, United States.
Jennifer M FetzerCenter for Biomedical Engineering, and ‡Department of Chemical and Biological Engineering, University of New Mexico , Albuquerque, New Mexico 87131, United States.
Steven W GravesCenter for Biomedical Engineering, and ‡Department of Chemical and Biological Engineering, University of New Mexico , Albuquerque, New Mexico 87131, United States.ORCID 0000-0001-6648-2194
Andrew P ShreveCenter for Biomedical Engineering, and ‡Department of Chemical and Biological Engineering, University of New Mexico , Albuquerque, New Mexico 87131, United States.ORCID 0000-0002-9567-3181
University of New Mexico · US

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
UNM Initiative to Maximize Student Diversity (IMSD)R25GM060201 · NIGMS · UNIVERSITY OF NEW MEXICO · PI WERNER-WASHBURNE, MARGRET C. · 2000 to 2017
$9.9M
Amplified detection of viral RNA using catalytic DNA logic circuitsR21AI115105 · NIAID · UNIVERSITY OF NEW MEXICO · PI GRAVES, STEVEN W · 2015 to 2016
$378k
A biomimetic nanoparticle protease assay platformR21EB016339 · NIBIB · UNIVERSITY OF NEW MEXICO · PI GRAVES, STEVEN W · 2013 to 2014
$364k
NCI NIH HHS P30 CA118100NIAID NIH HHS R21 AI115105NIBIB NIH HHS R21 EB016339NIGMS NIH HHS R25 GM060201
6 · The paper itself

Abstract

Most druggable targets are membrane components, including membrane proteins and soluble proteins that interact with ligands or receptors embedded in membranes. Current target-based screening and intermolecular interaction assays generally do not include the lipid membrane environment in presenting these targets, possibly altering their native structure and leading to misleading or incorrect results. To address this issue, an ideal assay involving membrane components would (1) mimic the natural membrane environment, (2) be amenable to high-throughput implementation, and (3) be easily multiplexed. In a step toward developing such an ideal target-based analytical assay for membrane components, we present fluorescently indexed multiplexed biomimetic membrane assays amenable to high-throughput flow cytometric detection. We build fluorescently multiplexed biomimetic membrane assays by using varying amounts of a fluorescently labeled lipid, NBD-DOPE [1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl)], incorporated into a phospholipid membrane bilayer supported on 3 μm silica microspheres. Using flow cytometry, we demonstrate this multiplexed approach by measuring specific affinity of two well-characterized systems, the fluorescently labeled soluble proteins cholera toxin B subunit-Alexa 647 and streptavidin-PE/Cy5, to membranes containing different amounts of ligand targets of these proteins, GM1 and biotin-DOPE, respectively. This work will enable future efforts in developing highly efficient biomimetic assays for interaction analysis and drug screening involving membrane components.

Indexed as

MicrospheresCholera ToxinFlow CytometryFluorescent DyesLigandsLipid BilayersLipidsParticle SizeSilicon DioxideStreptavidinSurface PropertiesCholera ToxinFluorescent DyesLigandsLipid BilayersLipidsSilicon DioxideStreptavidin

Identifiers

PMID28558200
PMCPMC6342469
OpenAlexW2620139703

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.